Invenia ABUS Premium is GE HealthCare’s advanced AI-driven 3D automated breast ultrasound solution, specifically designed to complement mammography in women with dense breasts. Combining automated standardized scanning, cSound Imageformer, the Reverse Curve transducer, AI-powered scan assessment, Auto Nipple Detection, QVCAD™, and Koios DS™ Breast, it delivers reproducible whole-breast imaging, efficient workflow, and advanced tools for lesion detection and characterization. GE reports a 35.7% increase in cancer detection over mammography alone in dense breasts, positioning Invenia ABUS as a powerful supplemental screening solution for modern breast-care programs.
Invenia ABUS (Automated Breast Ultrasound System) is GE HealthCare’s dedicated 3D automated breast ultrasound platform, specifically designed for supplemental breast cancer screening in women with dense breast tissue. It provides standardized, operator-independent breast imaging and creates a complete 3D volume of the breast for detailed review. GE HealthCare currently promotes the latest generation as Invenia ABUS Premium.
Unlike conventional handheld breast ultrasound, ABUS automatically acquires large-volume 3D datasets of the breast.
This provides:
The latest system uses GE’s cSound Imageformer software-based processing technology, which automatically focuses at every pixel to generate high-quality, reproducible images.
GE also reports a 40% faster scan speed compared with Invenia ABUS 2.0.
The latest ABUS Premium incorporates a 15.3 cm Reverse Curve transducer designed to follow the natural contour of the breast.
Benefits include:
AI evaluates the acquisition to provide immediate qualitative feedback regarding:
This helps improve consistency between examinations and operators.
Automatically identifies and marks the nipple position, helping standardize acquisition and reduce scanning time.
Invenia ABUS Premium integrates AI-assisted reading through the Invenia ABUS Viewer, incorporating third-party AI technologies such as QVCAD™ and Koios DS™ Breast.
GE reports that QVCAD can provide up to 93% sensitivity for lesion detection and reduce reading time by approximately 33%. Koios DS Breast is designed to assist lesion characterization and may reduce benign biopsies by up to 55%.
The main clinical purpose of Invenia ABUS is supplemental screening for women with dense breasts.
Dense breast tissue and many breast cancers both appear white on mammography, potentially making cancers more difficult to detect. ABUS provides a different imaging modality that can reveal lesions that may be obscured on mammography.
GE reports that Invenia ABUS has demonstrated a 35.7% increase in cancer detection compared with mammography alone in dense breasts.
Invenia ABUS can support several stages of breast care:
The complete 3D breast volume can help visualize:
Reproducible ABUS volumes can be compared with previous examinations to monitor changes and treatment response.
Invenia ABUS separates image acquisition from interpretation, allowing trained technologists to perform standardized scans while radiologists can review the examinations remotely.
The system is designed to provide:
ABUS is:
The latest Reverse Curve transducer is specifically designed to follow the breast’s natural contour and improve patient comfort.
Primary application:
Additional applications:

open PDF